Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
Tesaro Shares Surge 82% Because Drug Slows Ovarian Cancer
Forbes
Wed, 06/29/16 - 10:51 am
Tesaro
ovarian cancer
niraparib
clinical trials
Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302
Yahoo
Sat, 06/11/16 - 09:59 am
Galeana Biopharma
orphan drugs
ovarian cancer
GALE-301
GALE-301/GALE-302
Clovis Oncology Presents Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer and Pancreatic Cancer at 2016 ASCO Annual Meeting
Yahoo
Mon, 06/6/16 - 11:04 am
Clovis Oncology
rucaparib
ovarian cancer
pancreatic cancer
ASCO 2016
LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer
Yahoo
Mon, 06/6/16 - 10:31 am
Lynparza
olaparib
ovarian cancer
AstraZeneca
ASCO 2016
J&J loses another talcum powder case, ordered to pay victim $55 million
BioPharma Dive
Thu, 05/5/16 - 09:35 am
JNJ
ovarian cancer
TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute
Yahoo
Thu, 04/21/16 - 03:14 pm
TapImmune
AstraZenca
MedImmune
ovarian cancer
clinical trials
TPIV 200
Array Bio ends late-stage study of ovarian cancer drug
Yahoo/Reuters
Fri, 04/1/16 - 10:16 am
Array Biopharma
clinical trials
ovarian cancer
binimetinib
Oxigene Receives Fast Track Designation From U.S. FDA for CA4P
Yahoo
Wed, 03/30/16 - 10:15 am
Oxigene
fast track
FDA
CA4P
ovarian cancer
platinum-resistant ovarian cancer
Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Yahoo
Thu, 03/3/16 - 10:44 am
Merck
Pfizer
Verastem
ovarian cancer
clinical trials
avelumab
VS-6063
J&J Must Pay $72 Million Over Talc Tied to Woman's Cancer
Bloomberg
Tue, 02/23/16 - 09:49 am
JNJ
consumer health
ovarian cancer
Pfizer, Merck KGaA launch two more PhIII trials for avelumab
Fierce Biotech
Tue, 12/22/15 - 10:00 pm
Pfizer
Merck KGaA
avelumab
ovarian cancer
anti-PD-L1
ImmunoGen Refines Drug Targeting for Ovarian Cancer Patients
TheStreet.com
Mon, 11/9/15 - 09:33 am
Immunogen
ovarian cancer
mirvetuximab soravtansin
clinical trials
AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients
Fierce Biotech
Fri, 10/30/15 - 11:17 am
AstraZeneca
olaparib
Lynparza
prostate cancer
ovarian cancer
Cellceutix Plans for Phase 2 Clinical Trial in Ovarian Cancer
Yahoo
Tue, 09/8/15 - 01:58 pm
Cellceutix
clinical trials
ovarian cancer
Kevetrin
From Cancer To Ebola, NewLink Genetics Seeks Vaccines
Investors.com
Sat, 08/22/15 - 08:54 am
vaccines
NewLink Genetics
ebola virus
cancer
ovarian cancer
Clovis Oncology’s Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Highly Compelling Clinical Activity
Yahoo
Sat, 05/30/15 - 05:41 pm
Clovis Oncology
ASCO
rucaparib
ovarian cancer
Clovis Jumps After Hours On Accelerated Review Of Ovarian Cancer Drug
Barron's
Mon, 04/6/15 - 06:12 pm
Clovis Oncology
rucaparib
ovarian cancer
Celsion Jumps On Interim Data On Cancer Drug
Yahoo/Benzinga
Fri, 02/20/15 - 06:03 pm
Celsion
GEN-1
ovarian cancer
Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation
Drug Discovery and Development
Mon, 01/26/15 - 09:42 am
Aprea
Europe
ovarian cancer
APR-246
Cancer-fighting Vermillion secures $10.5M to keep its doors open
Bizjournals.com
Wed, 12/24/14 - 09:00 am
Vermillion
ovarian cancer
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »